Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Acadian Asset Management Incorporated Earnings Conference Call and Webcast for the Fourth Quarter 2024.
Acelia Pharma reported its Q4 2024 earnings, focusing on its strategic advancements and financial stability. The company announced an operating loss of 21.9 million kronor, while maintaining a cash ...
The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.51 per share. Philip Morris expects full-year earnings in the range of $7.04 to $7.17 per share. This ...
Neurocrine Biosciences (NBIX) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.44 per share a year ago. These ...
Results that may be inaccessible to you are currently showing.